Kala Pharmaceuticals
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$11.24M N/A	$3.89M -65.37%	$0 -100%	Avg: $41.34M Low: $41.34M High: $41.34M avg. 0%	Avg: $25M Low: $25M High: $25M avg. -39.53%	Avg: $26.11M Low: $26.11M High: $26.11M avg. 4.47%
Net Income % change YoY	$-152.29M N/A	$-223K 99.85%	$-42.19M -18823.31%	Avg: $-18.41M Low: $-18.41M High: $-18.41M avg. 56.37%	Avg: $-10.40M Low: $-10.40M High: $-10.40M avg. 43.46%	Avg: $-22.64M Low: $-22.64M High: $-22.64M avg. -117.52%
EBITDA % change YoY	$-107.04M N/A	$-81.61M 23.75%	$-36.08M 55.79%	Avg: $-24.80M Low: $-24.80M High: $-24.80M avg. 31.24%	Avg: $-15M Low: $-15M High: $-15M avg. 39.53%	Avg: $-15.67M Low: $-15.67M High: $-15.67M avg. -4.47%
EPS % change YoY	-$116.79 N/A	-$0.15 99.87%	-$17.35 -11466.66%	Avg: -$7.57 Low: -$7.57 High: -$7.57 avg. 56.36%	Avg: -$4.28 Low: -$4.28 High: -$4.28 avg. 43.46%	Avg: -$9.31 Low: -$9.31 High: -$9.31 avg. -117.52%
Operating Expenses % change YoY	$116.57M N/A	$82.68M -29.06%	$39.15M -52.64%	Avg: $417.62M Low: $417.62M High: $417.62M avg. 966.64%	Avg: $252.51M Low: $252.51M High: $252.51M avg. -39.53%	Avg: $263.80M Low: $263.80M High: $263.80M avg. 4.47%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of -5.89% in 2025-2027.

We have gathered data from N/A analysts. Their low estimate is -18.41M, average is -18.41M and high is -18.41M.

Wall Street analysts forecast annual average revenue growth of -11.68% in 2025-2027.

We have gathered data from N/A analysts. Their low revenue estimate is $41.34M, average is $41.34M and high is $41.34M.

Wall Street analysts forecast annual average earnings growth of -5.89% in 2025-2027.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$7.57, average is -$7.57 and high is $-7.57.